EXTRA-PANCREATIC NEUROENDOCRINE TUMOR (EPNET)

Clinical trials for EXTRA-PANCREATIC NEUROENDOCRINE TUMOR (EPNET) explained in plain language.

Never miss a new study

Get alerted when new EXTRA-PANCREATIC NEUROENDOCRINE TUMOR (EPNET) trials appear

Sign up with your email to follow new studies for EXTRA-PANCREATIC NEUROENDOCRINE TUMOR (EPNET), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for advanced neuroendocrine cancer patients in major drug trial

Disease control Recruiting now

This study is testing whether a new drug called zanzalintinib works better than the current standard drug everolimus for people with advanced neuroendocrine tumors that have grown despite previous treatments. The trial will enroll 440 participants whose cancer cannot be surgicall…

Matched conditions: EXTRA-PANCREATIC NEUROENDOCRINE TUMOR (EPNET)

Phase: PHASE2, PHASE3 • Sponsor: Exelixis • Aim: Disease control

Last updated Mar 17, 2026 13:08 UTC

EXTRA-PANCREATIC NEUROENDOCRINE TUMOR (EPNET)

Get alerted when new EXTRA-PANCREATIC NEUROENDOCRINE TUMOR (EPNET) trials appear

New hope for advanced neuroendocrine cancer patients in major drug trial